<DOC>
	<DOCNO>NCT00624962</DOCNO>
	<brief_summary>RATIONALE : Tubefeeding may help maintain good nutrition lessen weight loss younger patient receive chemotherapy cancer . PURPOSE : This clinical trial study well tube feeding work young patient receive chemotherapy newly diagnose acute myeloid leukemia , myelodysplastic syndrome , high-risk solid tumor .</brief_summary>
	<brief_title>Early Enteral Tube Feedings Children Receiving Chemo AML/MDS &amp; High Risk Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine feasibility acceptance undertake early enteral tube feeding child receive induction chemotherapy newly diagnose acute myeloid leukemia myelodysplastic syndrome , primary cancer central nervous system , high-risk solid tumor . Secondary - To determine safety proactive enteral nutrition patient . - To evaluate effect enteral nutrition nutritional status patient . OUTLINE : Patients small ( 6 8 French ) nasogastral feed tube enterostomy tube insert diagnosis . PeptamenÂ® AF tube feeding administer via enteral tube . Tube feeding start continuous drip use enteral feed pump subsequent steady daily rate increase . Patients receive enteral feeding course 1-4 chemotherapy .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>Newly confirm diagnosis 1 following : Acute myeloid leukemia Myelodysplastic syndrome Sarcoma Any stage IV solid tumor include : Wilms Neuroblastoma Hepatoblastoma Any primary cancer central nervous system include : Cerebellar astrocytoma Medulloblastoma Ependymoma Spine tumors No contraindication enteral tube feed include , limited , follow : Gastrointestinal tract dysfunction ( i.e. , ileus , peritonitis , obstruction ) Active sinusitis ( waived patient gastrostomy tube ) Obstructive tumor nasopharynx PRIOR CONCURRENT THERAPY : No prior hematopoietic stem cell transplant All clinically indicate medication permit course study No concurrent nutritional supplement</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>childhood soft tissue sarcoma</keyword>
	<keyword>neuroblastoma</keyword>
	<keyword>childhood hepatoblastoma</keyword>
	<keyword>childhood cerebellar astrocytoma</keyword>
	<keyword>childhood ependymoma</keyword>
	<keyword>childhood brain stem glioma</keyword>
	<keyword>childhood meningioma</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>central nervous system neoplasm</keyword>
	<keyword>Wilms tumor childhood kidney tumor</keyword>
	<keyword>childhood brain tumor</keyword>
	<keyword>childhood medulloblastoma</keyword>
</DOC>